Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN™ prosthesis: Incidence and impact on outcome

Gregory Ducrocq, Fady Francis, Jean Michel Serfaty, Dominique Himbert, Jean Michel Maury, Nicoletta Pasi, Sami Marouene, Sophie Provenchère, Bernard Iung, Yves Castier, Guy Lesèche, Alec Vahanian

Research output: Contribution to journalArticle

Abstract

Aims: Vascular complications remain the main limitation of transfemoral aortic valve implantation. Based on a single-centre experience, we aim to detail the type, management and impact of those vascular complications. Methods and results: From October 2006 to January 2009, 54 transfemoral aortic valve implantations were performed using the Edwards SAPIEN™ prosthesis. Nine patients (16.7%) developed vascular complications. Five patients (9.3%) had ruptures which necessitated a surgical bypass. Four patients (7.4%) had dissection necessitating repair using stenting in all four patients and associated bypass in two of them. Vascular complications led to death in one patient (1.9%), reintervention in one (1.9%), and transfusions in seven (13%). Five vascular complications occurred in the first 20 patients (25%), and only four in the last 34 (12%). Conclusions: Vascular complications of transfemoral aortic valve implantation are frequent and seem to be influenced by experience. They are associated with a high need for transfusion and could lead to major events such as death or reintervention. These findings highlight the importance of a multidisciplinary approach for patient selection and management of the procedure.

Original languageEnglish (US)
Pages (from-to)666-672
Number of pages7
JournalEuroIntervention
Volume5
Issue number6
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Aortic Valve
Prostheses and Implants
Blood Vessels
Incidence
Patient Selection
Dissection
Rupture

Keywords

  • Transfemoral aortic valve implantation
  • Vascular complications

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN™ prosthesis : Incidence and impact on outcome. / Ducrocq, Gregory; Francis, Fady; Serfaty, Jean Michel; Himbert, Dominique; Maury, Jean Michel; Pasi, Nicoletta; Marouene, Sami; Provenchère, Sophie; Iung, Bernard; Castier, Yves; Lesèche, Guy; Vahanian, Alec.

In: EuroIntervention, Vol. 5, No. 6, 01.2010, p. 666-672.

Research output: Contribution to journalArticle

Ducrocq, G, Francis, F, Serfaty, JM, Himbert, D, Maury, JM, Pasi, N, Marouene, S, Provenchère, S, Iung, B, Castier, Y, Lesèche, G & Vahanian, A 2010, 'Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN™ prosthesis: Incidence and impact on outcome', EuroIntervention, vol. 5, no. 6, pp. 666-672. https://doi.org/10.4244/EIJV5I6A110
Ducrocq, Gregory ; Francis, Fady ; Serfaty, Jean Michel ; Himbert, Dominique ; Maury, Jean Michel ; Pasi, Nicoletta ; Marouene, Sami ; Provenchère, Sophie ; Iung, Bernard ; Castier, Yves ; Lesèche, Guy ; Vahanian, Alec. / Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN™ prosthesis : Incidence and impact on outcome. In: EuroIntervention. 2010 ; Vol. 5, No. 6. pp. 666-672.
@article{11799dfbcd684749b86c947939e8baf7,
title = "Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN™ prosthesis: Incidence and impact on outcome",
abstract = "Aims: Vascular complications remain the main limitation of transfemoral aortic valve implantation. Based on a single-centre experience, we aim to detail the type, management and impact of those vascular complications. Methods and results: From October 2006 to January 2009, 54 transfemoral aortic valve implantations were performed using the Edwards SAPIEN™ prosthesis. Nine patients (16.7{\%}) developed vascular complications. Five patients (9.3{\%}) had ruptures which necessitated a surgical bypass. Four patients (7.4{\%}) had dissection necessitating repair using stenting in all four patients and associated bypass in two of them. Vascular complications led to death in one patient (1.9{\%}), reintervention in one (1.9{\%}), and transfusions in seven (13{\%}). Five vascular complications occurred in the first 20 patients (25{\%}), and only four in the last 34 (12{\%}). Conclusions: Vascular complications of transfemoral aortic valve implantation are frequent and seem to be influenced by experience. They are associated with a high need for transfusion and could lead to major events such as death or reintervention. These findings highlight the importance of a multidisciplinary approach for patient selection and management of the procedure.",
keywords = "Transfemoral aortic valve implantation, Vascular complications",
author = "Gregory Ducrocq and Fady Francis and Serfaty, {Jean Michel} and Dominique Himbert and Maury, {Jean Michel} and Nicoletta Pasi and Sami Marouene and Sophie Provench{\`e}re and Bernard Iung and Yves Castier and Guy Les{\`e}che and Alec Vahanian",
year = "2010",
month = "1",
doi = "10.4244/EIJV5I6A110",
language = "English (US)",
volume = "5",
pages = "666--672",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
number = "6",

}

TY - JOUR

T1 - Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN™ prosthesis

T2 - Incidence and impact on outcome

AU - Ducrocq, Gregory

AU - Francis, Fady

AU - Serfaty, Jean Michel

AU - Himbert, Dominique

AU - Maury, Jean Michel

AU - Pasi, Nicoletta

AU - Marouene, Sami

AU - Provenchère, Sophie

AU - Iung, Bernard

AU - Castier, Yves

AU - Lesèche, Guy

AU - Vahanian, Alec

PY - 2010/1

Y1 - 2010/1

N2 - Aims: Vascular complications remain the main limitation of transfemoral aortic valve implantation. Based on a single-centre experience, we aim to detail the type, management and impact of those vascular complications. Methods and results: From October 2006 to January 2009, 54 transfemoral aortic valve implantations were performed using the Edwards SAPIEN™ prosthesis. Nine patients (16.7%) developed vascular complications. Five patients (9.3%) had ruptures which necessitated a surgical bypass. Four patients (7.4%) had dissection necessitating repair using stenting in all four patients and associated bypass in two of them. Vascular complications led to death in one patient (1.9%), reintervention in one (1.9%), and transfusions in seven (13%). Five vascular complications occurred in the first 20 patients (25%), and only four in the last 34 (12%). Conclusions: Vascular complications of transfemoral aortic valve implantation are frequent and seem to be influenced by experience. They are associated with a high need for transfusion and could lead to major events such as death or reintervention. These findings highlight the importance of a multidisciplinary approach for patient selection and management of the procedure.

AB - Aims: Vascular complications remain the main limitation of transfemoral aortic valve implantation. Based on a single-centre experience, we aim to detail the type, management and impact of those vascular complications. Methods and results: From October 2006 to January 2009, 54 transfemoral aortic valve implantations were performed using the Edwards SAPIEN™ prosthesis. Nine patients (16.7%) developed vascular complications. Five patients (9.3%) had ruptures which necessitated a surgical bypass. Four patients (7.4%) had dissection necessitating repair using stenting in all four patients and associated bypass in two of them. Vascular complications led to death in one patient (1.9%), reintervention in one (1.9%), and transfusions in seven (13%). Five vascular complications occurred in the first 20 patients (25%), and only four in the last 34 (12%). Conclusions: Vascular complications of transfemoral aortic valve implantation are frequent and seem to be influenced by experience. They are associated with a high need for transfusion and could lead to major events such as death or reintervention. These findings highlight the importance of a multidisciplinary approach for patient selection and management of the procedure.

KW - Transfemoral aortic valve implantation

KW - Vascular complications

UR - http://www.scopus.com/inward/record.url?scp=77954141480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954141480&partnerID=8YFLogxK

U2 - 10.4244/EIJV5I6A110

DO - 10.4244/EIJV5I6A110

M3 - Article

C2 - 20142216

AN - SCOPUS:77954141480

VL - 5

SP - 666

EP - 672

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

IS - 6

ER -